Emergence is supported by a network of world-leading experts in immuno-oncology and leading European investors. Kurma Partners led the Company’s seed funding round and acted as the originator and incubator investor. Further investors and partners include Bpifrance, Gründerfonds Ruhr, Heidelberg Pharma Research GmbH, High-Tech Gründerfonds, idinvest Partners and NRW.Bank.




ETX Investors
& Partners

Bpi France


Gründerfonds Ruhr

Heidelberg Pharma

High-Tech Gründerfonds

idinvest Partners